These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25006738)

  • 41. Molecular stool screening for colorectal cancer. Using DNA markers may be beneficial, but large scale evaluation is needed.
    Ahlquist DA
    BMJ; 2000 Jul; 321(7256):254-5. PubMed ID: 10915110
    [No Abstract]   [Full Text] [Related]  

  • 42. Stool and Blood DNA Tests for Colorectal Cancer Screening. Reply.
    Chung DC; Raymond VM; Grady WM
    N Engl J Med; 2024 Jun; 390(23):2224-2225. PubMed ID: 38899711
    [No Abstract]   [Full Text] [Related]  

  • 43. [Application and prospect of fecal DNA test in colorectal cancer screening].
    Ma CX; Guan X; Wang S; Liu Z; Jiang Z; Wang XS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 May; 22(5):491-494. PubMed ID: 31104434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Colorectal cancer screening at Clínica Alemana, Santiago de Chile].
    Silva Mde L; Santander R; Gobelet J; Valdivieso E; Ramírez MA; Sáenz R; Alarcón G; Elías S; Olivares L
    Acta Gastroenterol Latinoam; 2011 Mar; 41(1):10-6. PubMed ID: 21539063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection.
    Pickhardt PJ
    Abdom Radiol (NY); 2016 Aug; 41(8):1441-4. PubMed ID: 27259335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel molecular screening approaches in colorectal cancer.
    Miller S; Steele S
    J Surg Oncol; 2012 Apr; 105(5):459-67. PubMed ID: 22441897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology and screening: what's new?
    Bonelli L
    Colorectal Dis; 2015 Jan; 17 Suppl 1():10-4. PubMed ID: 25511855
    [No Abstract]   [Full Text] [Related]  

  • 49. New gene discoveries may boost DNA stool testing for colorectal cancer.
    Garber K
    J Natl Cancer Inst; 2004 Jun; 96(11):820-1. PubMed ID: 15173262
    [No Abstract]   [Full Text] [Related]  

  • 50. [Gene methylation in stool for the screening of colorectal cancer and pre-malignant lesions].
    Kang YP; Cao FA; Chang WJ; Lou Z; Wang H; Wu LL; Fu CG; Cao GW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):52-6. PubMed ID: 21271382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Off-Label Use of Multitarget Stool DNA Testing in Primary Care.
    Agarwal A; Zhang T; Ravindran N; Thuluvath PJ; Maheshwari A
    Am J Gastroenterol; 2021 Apr; 116(4):829-832. PubMed ID: 33982956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colorectal Cancer Screening by Stool DNA Testing and Patient Emotional Health.
    Simpson WG
    Am J Gastroenterol; 2019 May; 114(5):829. PubMed ID: 30848736
    [No Abstract]   [Full Text] [Related]  

  • 53. Colorectal Adenomas.
    Strum WB
    N Engl J Med; 2016 Mar; 374(11):1065-75. PubMed ID: 26981936
    [No Abstract]   [Full Text] [Related]  

  • 54. A Stool Multitarget mRNA Assay for the Detection of Colorectal Neoplasms.
    Herring E; Kanaoka S; Tremblay E; Beaulieu JF
    Methods Mol Biol; 2018; 1765():217-227. PubMed ID: 29589311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A next-generation mt-sDNA test had 94% sensitivity for colorectal cancer and 91% specificity for advanced neoplasia.
    van Zanten SV; Kuipers EJ
    Ann Intern Med; 2024 Sep; 177(9):JC107. PubMed ID: 39222515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multitarget Stool RNA Testing.
    Imperiale TF; Lavin P; Ransohoff DF
    JAMA; 2024 Apr; 331(16):1418. PubMed ID: 38558154
    [No Abstract]   [Full Text] [Related]  

  • 57. Exact Sciences' experience with the FDA and CMS parallel review program.
    Ridge JR; Statz S
    Expert Rev Mol Diagn; 2015; 15(9):1117-24. PubMed ID: 26211481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strengthening the case for stool DNA tests as first-line colorectal cancer screening: are we there yet?
    Lucas AL; Hwang C; Frucht H
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):214-5. PubMed ID: 22138275
    [No Abstract]   [Full Text] [Related]  

  • 59. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
    Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stool DNA methylation assays in colorectal cancer screening.
    Kadiyska T; Nossikoff A
    World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.